Galapagos

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Galapagos and other ETFs, options, and stocks.

About GLPG

Galapagos NV is a biotechnology company, which engages in the identification and development of small molecule and antibody therapies. Its clinical pipeline includes filgotinib, GLP3667, Toledo program, and idiopathic pulmonary fibrosis.

CEO

Paulus Stoffels

CEOPaulus Stoffels

Employees

704

Employees704

Headquarters

Mechelen, Brussels Region

HeadquartersMechelen, Brussels Region

Founded

1999

Founded1999

Employees

704

Employees704

GLPG Key Statistics

Market cap

1.77B

Market cap1.77B

Price-Earnings ratio

-9.82

Price-Earnings ratio-9.82

Dividend yield

—

Dividend yield—

Average volume

563.76K

Average volume563.76K

High today

$26.97

High today$26.97

Low today

$26.49

Low today$26.49

Open price

$26.62

Open price$26.62

Volume

384.34K

Volume384.34K

52 Week high

$31.23

52 Week high$31.23

52 Week low

$22.36

52 Week low$22.36

GLPG News

TipRanks 2d

Galapagos NV Reports Q1 2025 Results and Strategic Updates

Galapagos NV ( (GLPG) ) has released its Q1 earnings. Here is a breakdown of the information Galapagos NV presented to its investors. Galapagos NV is a global...

TipRanks 3d

Galapagos reports Q1 EPS vs. EUR 1.40 last year

Reports Q1 revenue EUR 75M vs. EUR 62.4M last year. “We are making progress toward the planned separation announced early this year, positioning Galapagos (GLPG...

Analyst ratings

73%

of 11 ratings

Buy

9.1%

Hold

72.7%

Sell

18.2%